Cellibre

Building The Domestic Supply Chain For Critical Chemicals

About this Event

Cellibre is a leader in the fast growing biomanufacturing industry. It is a field that’s so critical to our national security that the U.S. Department of Defense plans to invest $1.2 billion to build distributed domestic biomanufacturing infrastructure over the next 5 years.

Cellibre has developed a highly differentiated, biological-based, platform technology to produce chemicals economically and at scale in the United States. The United States has lost significant market share of chemical production over the past 20 years, with the supply chains of myriad critical compounds moving to China.

This process allows Cellibre to go from concept to large-scale production in less than 10 months (90% cost savings), resulting in less expensive and more resilient supply chains. In addition, their platform uses far less energy, water and other natural resources.

Cellibre has several collaborations in place with major cosmetics brands and is rapidly expanding production with contract manufacturers.

Register today to watch this webinar with Cellibre CEO, Ben Chiarelli, to hear how their platform offers scalability across multiple industries, including defense, food, energy, pharmaceuticals, and industrial applications.

Video On Demand

– Recorded

May 21

SHARE THIS EVENT

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.